French National Agency for Medicines and Health Products Safety (ANSM), Saint Denis (France)
Follow
Contributor content
Presentation
Short-term risk of haemorrhage during heparin bridging at initiation of vitamin K antagonist therapy in patients with non-valvular atrial fibrillation managed in ambulatory care
